Quality of life during lanadelumab treatment in patients with hereditary angioedema: 24-month results from the enable study

被引：0
|
作者：
Saguer, I. Martinez [1 ]
Magerl, M. [2 ,3 ]
Andriotti, T. [4 ]
Botha, J. [5 ]
Agmon-Levin, N. [6 ]
Watt, M. [4 ]
Maurer, M. [3 ,7 ]
机构：
[1] HRZM Hemophilia Ctr Rhein Main, Morfelden Walldorf, Germany
[2] Charite Univ Med Berlin, Inst Allergol, Berlin, Germany
[3] Fraunhofer Inst Translat Med & Pharmacol ITMP, Berlin, Germany
[4] Takeda Dev Ctr Amer Inc, Lexington, KY USA
[5] Takeda Pharmaceut Int AG, Zurich, Switzerland
[6] Tel Hashomer Hosp, Ctr Autoimmune Dis, Sheba Med Ctr, Ramat Gan, Israel
[7] Charite Univ Med Berlin, Inst Allergol, Berlin, Germany
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000902
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [31] Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study
    Kutzelnigg A.
    Kopeinig M.
    Chen C.-K.
    Fábián Á.
    Pujol-Luna M.G.
    Shin Y.-C.
    Treuer T.
    D’yachkova Y.
    Deix C.
    Kasper S.
    Doby D.
    International Journal of Bipolar Disorders, 2 (1) : 1 - 14
  • [32] Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies
    Timothy J. Craig
    Rafael H. Zaragoza-Urdaz
    H. Henry Li
    Ming Yu
    Hong Ren
    Salomé Juethner
    John Anderson
    Allergy, Asthma & Clinical Immunology, 18
  • [33] Attack-free status during steady state of lanadelumab treatment in patients with -hereditary angioedema: findings from the HELP open-label extension study
    Magerl, M.
    Johnston, D. T.
    Lumry, W. R.
    Bernstein, J. A.
    Nurse, C.
    Yu, M.
    Riedl, M. A.
    ALLERGOLOGIE, 2022, 45 (08) : 606 - 606
  • [34] CARIES PROGRESSION IN PRIMARY MOLARS - 24-MONTH RESULTS FROM A MINIMAL TREATMENT PROGRAM
    CRAIG, GG
    POWELL, KR
    COOPER, MH
    COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 1981, 9 (06) : 260 - 265
  • [35] Garadacimab prophylaxis improves quality of life in adult and adolescent patients with hereditary angioedema: Results from a multicentre Phase 3 study
    Lumry, W.
    Magerl, M.
    Craig, T. J.
    Farkas, H.
    Yang, W.
    Stroes, E. S.
    Saguer, I. Martinez
    Aygoeren-Puersuen, E.
    Staubach, P.
    Treudler, R.
    Itzler, R.
    Feuersenger, H.
    Pragst, I.
    Reshef, A.
    ALLERGY, 2023, 78 : 114 - 115
  • [36] Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina
    Babini, A.
    Cappuccio, A. M.
    Caprarulo, C.
    Casado, G.
    Eimon, A.
    Figueredo, H.
    Garcia, M. A.
    Magri, S.
    Mannucci, P.
    Perez Rodriguez, S.
    Pons-Estel, B. A.
    Velozo, E. J.
    Iglesias-Rodriguez, M.
    Streger, G.
    LUPUS, 2020, 29 (11) : 1385 - 1396
  • [37] JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam
    Chiriboga, Claudia A.
    Bruno, Claudio
    Duong, Tina
    Fischer, Dirk
    Mercuri, Eugenio
    Kirschner, Janbernd
    Kostera-Pruszczyk, Anna
    Jaber, Birgit
    Gorni, Ksenija
    Kletzl, Heidemarie
    Carruthers, Imogen
    Martin, Carmen
    Scalco, Renata S.
    Fontoura, Paulo
    Muntoni, Francesco
    JOURNAL OF NEUROLOGY, 2024, 271 (08) : 4871 - 4884
  • [38] Characteristics of Patients with Hereditary Angioedema Who Reduced Lanadelumab Treatment Administration Frequency: A Retrospective Observational Study of US Claims Data
    Princic, Nicole
    Evans, Kristin A.
    Shah, Chintal H.
    Sing, Krystal
    Juethner, Salome
    Schultz, Bob G.
    DRUGS-REAL WORLD OUTCOMES, 2025, 12 (01) : 17 - 24
  • [39] Consistent Lanadelumab Treatment Effect In Patients With Hereditary Angioedema (HAE) Regardless Of Baseline Attack Frequency In The Phase 3 HELP Study
    Riedl, Marc A.
    Tachdjian, Raffi
    Schranz, Jennifer
    Nurse, Christina
    Bernstein, Jonathan A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB47 - AB47
  • [40] Vitamin D supplementation and quality of life following diagnosis in stage II colorectal cancer patients: a 24-month prospective study
    Lewis, Cari
    Xun, Pengcheng
    He, Ka
    SUPPORTIVE CARE IN CANCER, 2016, 24 (04) : 1655 - 1661
12345